Class Action Alleges Plot To Price-Fix Plasma Therapies

Law360, New York (November 11, 2009, 4:55 PM EST) -- Pharmaceutical companies CSL Ltd. Co. and Baxter International Inc. are facing class action allegations that they conspired to fix the prices of plasma-derivative protein therapies.

In a 66-page amended complaint filed Tuesday with the U.S. District Court for the Eastern District of Pennsylvania, plaintiff Pemiscot Memorial Hospital alleges that because of the defendants' actions, members of a proposed class paid improperly high prices for the plasma-derivative protein therapies.

Plasma-derivative protein therapies, according to the complaint, are used to treat critically ill patients suffering from various immune...
To view the full article, register now.